Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Ameren
AEE
$30.1B
| $3.23M | ﹤0.01% |
37,375
+151
| +0.4% | +$12.9K |
|
|
ATSG
1027
DELISTED
Air Transport Services Group
ATSG
| $3.22M | ﹤0.01% |
154,474
+134,045
| +656% | +$3.24M |
|
|
APGB
1028
DELISTED
Apollo Strategic Growth Capital II
APGB
| $3.21M | ﹤0.01% |
313,430
-332
| -0.1% | -$3.37K |
|
1029
Trex
TREX
$5.05B
| $3.2M | ﹤0.01% |
65,761
+31,650
| +93% | +$1.6M |
|
1030
Inspire Medical Systems
INSP
$1.69B
| $3.19M | ﹤0.01% |
13,634
+7,737
| +131% | +$1.96M |
|
1031
Jones Lang LaSalle
JLL
$16.7B
| $3.18M | ﹤0.01% |
21,887
+12,813
| +141% | +$2.14M |
|
1032
VeriSign
VRSN
$25.6B
| $3.18M | ﹤0.01% |
15,049
-46,517
| -76% | -$9.59M |
|
1033
First Industrial Realty Trust
FR
$8.4B
| $3.18M | ﹤0.01% |
59,764
+35,987
| +151% | +$1.88M |
|
1034
Ares Capital
ARCC
$14.3B
| $3.18M | ﹤0.01% |
+173,845
| New | +$3.29M |
|
1035
CACI
CACI
$15B
| $3.17M | ﹤0.01% |
10,699
+6,243
| +140% | +$1.84M |
|
1036
Mueller Industries
MLI
$15.1B
| $3.16M | ﹤0.01% |
172,200
+49,084
| +40% | +$857K |
|
1037
Nutanix
NTNX
$17.5B
| $3.15M | ﹤0.01% |
121,192
+75,995
| +168% | +$2.06M |
|
1038
Baxter International
BAX
$13.9B
| $3.15M | ﹤0.01% |
77,565
-144,049
| -65% | -$6.11M |
|
1039
Texas Roadhouse
TXRH
$14.1B
| $3.14M | ﹤0.01% |
29,083
+18,901
| +186% | +$1.93M |
|
|
HPP
1040
Hudson Pacific Properties
HPP
$776M
| $3.13M | ﹤0.01% |
67,368
+7,251
| +12% | +$466K |
|
|
SHAP
1041
DELISTED
Spree Acquisition Corp. 1 Limited
SHAP
| $3.13M | ﹤0.01% |
300,000
| – | – |
|
1042
Ingredion
INGR
$6.54B
| $3.13M | ﹤0.01% |
30,737
+17,649
| +135% | +$1.76M |
|
1043
Veeva Systems
VEEV
$39.3B
| $3.12M | ﹤0.01% |
17,009
+15
| +0.1% | +$2.56K |
|
1044
AGNC Investment
AGNC
$12.9B
| $3.1M | ﹤0.01% |
308,141
+155,556
| +102% | +$1.69M |
|
1045
Franklin Electric
FELE
$4.75B
| $3.1M | ﹤0.01% |
32,996
+25,017
| +314% | +$2.26M |
|
1046
National Health Investors
NHI
$3.47B
| $3.09M | ﹤0.01% |
59,892
+10,750
| +22% | +$586K |
|
1047
DigitalOcean
DOCN
$15.7B
| $3.09M | ﹤0.01% |
78,831
+68,805
| +686% | +$2.17M |
|
|
CMA
1048
DELISTED
Comerica
CMA
| $3.09M | ﹤0.01% |
71,086
+12,237
| +21% | +$784K |
|
1049
RBC Bearings
RBC
$17.6B
| $3.08M | ﹤0.01% |
13,231
+7,493
| +131% | +$1.73M |
|
1050
Valmont Industries
VMI
$9.52B
| $3.07M | ﹤0.01% |
9,633
+5,459
| +131% | +$1.74M |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.